1. Home
  2. VERA vs NMIH Comparison

VERA vs NMIH Comparison

Compare VERA & NMIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • NMIH
  • Stock Information
  • Founded
  • VERA 2016
  • NMIH 2011
  • Country
  • VERA United States
  • NMIH United States
  • Employees
  • VERA N/A
  • NMIH N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • NMIH Property-Casualty Insurers
  • Sector
  • VERA Health Care
  • NMIH Finance
  • Exchange
  • VERA Nasdaq
  • NMIH Nasdaq
  • Market Cap
  • VERA 2.8B
  • NMIH 3.2B
  • IPO Year
  • VERA 2021
  • NMIH 2013
  • Fundamental
  • Price
  • VERA $43.91
  • NMIH $37.69
  • Analyst Decision
  • VERA Strong Buy
  • NMIH Buy
  • Analyst Count
  • VERA 9
  • NMIH 7
  • Target Price
  • VERA $59.22
  • NMIH $43.14
  • AVG Volume (30 Days)
  • VERA 434.6K
  • NMIH 453.3K
  • Earning Date
  • VERA 11-07-2024
  • NMIH 02-12-2025
  • Dividend Yield
  • VERA N/A
  • NMIH N/A
  • EPS Growth
  • VERA N/A
  • NMIH 18.41
  • EPS
  • VERA N/A
  • NMIH 4.37
  • Revenue
  • VERA N/A
  • NMIH $635,847,000.00
  • Revenue This Year
  • VERA N/A
  • NMIH N/A
  • Revenue Next Year
  • VERA N/A
  • NMIH $7.13
  • P/E Ratio
  • VERA N/A
  • NMIH $8.71
  • Revenue Growth
  • VERA N/A
  • NMIH 13.40
  • 52 Week Low
  • VERA $14.20
  • NMIH $28.59
  • 52 Week High
  • VERA $51.61
  • NMIH $42.49
  • Technical
  • Relative Strength Index (RSI)
  • VERA 38.70
  • NMIH 41.50
  • Support Level
  • VERA $43.13
  • NMIH $37.72
  • Resistance Level
  • VERA $49.77
  • NMIH $38.66
  • Average True Range (ATR)
  • VERA 1.97
  • NMIH 0.84
  • MACD
  • VERA -0.74
  • NMIH -0.15
  • Stochastic Oscillator
  • VERA 10.79
  • NMIH 15.86

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About NMIH NMI Holdings Inc.

NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.

Share on Social Networks: